261 related articles for article (PubMed ID: 30387148)
1. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane.
Bignon M; Pichol-Thievend C; Hardouin J; Malbouyres M; Bréchot N; Nasciutti L; Barret A; Teillon J; Guillon E; Etienne E; Caron M; Joubert-Caron R; Monnot C; Ruggiero F; Muller L; Germain S
Blood; 2011 Oct; 118(14):3979-89. PubMed ID: 21835952
[TBL] [Abstract][Full Text] [Related]
3. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
4. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1.
Kim BR; Dong SM; Seo SH; Lee JH; Lee JM; Lee SH; Rho SB
Cell Signal; 2014 Sep; 26(9):1765-73. PubMed ID: 24863880
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
[TBL] [Abstract][Full Text] [Related]
6. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
Tanaka N; Yamada S; Sonohara F; Suenaga M; Hayashi M; Takami H; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
Sci Rep; 2018 Jun; 8(1):9846. PubMed ID: 29959362
[TBL] [Abstract][Full Text] [Related]
7. Scavenger Receptor Cysteine-Rich domains of Lysyl Oxidase-Like2 regulate endothelial ECM and angiogenesis through non-catalytic scaffolding mechanisms.
Umana-Diaz C; Pichol-Thievend C; Marchand MF; Atlas Y; Salza R; Malbouyres M; Barret A; Teillon J; Ardidie-Robouant C; Ruggiero F; Monnot C; Girard P; Guilluy C; Ricard-Blum S; Germain S; Muller L
Matrix Biol; 2020 Jun; 88():33-52. PubMed ID: 31759052
[TBL] [Abstract][Full Text] [Related]
8. LOXL2 in cancer: regulation, downstream effectors and novel roles.
Wen B; Xu LY; Li EM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
[TBL] [Abstract][Full Text] [Related]
9. Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma.
Kim IK; Lee YS; Kim HS; Dong SM; Park JS; Yoon DS
Sci Rep; 2019 Apr; 9(1):5933. PubMed ID: 30976063
[TBL] [Abstract][Full Text] [Related]
10. Neural Wiskott-Aldrich syndrome protein (N-WASP) promotes distant metastasis in pancreatic ductal adenocarcinoma via activation of LOXL2.
Kim HS; Lee YS; Dong SM; Kim HJ; Lee DE; Kang HW; Kim MJ; Park JS
Oncol Res; 2024; 32(4):615-624. PubMed ID: 38560567
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia.
Xu XH; Jia Y; Zhou X; Xie D; Huang X; Jia L; Zhou Q; Zheng Q; Zhou X; Wang K; Jin LP
Exp Mol Med; 2019 Feb; 51(2):1-12. PubMed ID: 30804321
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL
Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405
[TBL] [Abstract][Full Text] [Related]
13. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
14. LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity.
Almacellas-Rabaiget O; Monaco P; Huertas-Martinez J; García-Monclús S; Chicón-Bosch M; Maqueda-Marcos S; Fabra-Heredia I; Herrero-Martín D; Rello-Varona S; de Alava E; López-Alemany R; Giangrande PH; Tirado OM
Cancer Lett; 2020 Apr; 474():1-14. PubMed ID: 31911079
[TBL] [Abstract][Full Text] [Related]
15. MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.
Moon HJ; Finney J; Xu L; Moore D; Welch DR; Mure M
J Biol Chem; 2013 Oct; 288(42):30000-30008. PubMed ID: 24014025
[TBL] [Abstract][Full Text] [Related]
16. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
Wang C; Xu S; Tian Y; Ju A; Hou Q; Liu J; Fu Y; Luo Y
Neoplasia; 2019 Apr; 21(4):413-427. PubMed ID: 30925417
[TBL] [Abstract][Full Text] [Related]
17. Escin Ia suppresses the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expression.
Wang Y; Xu X; Zhao P; Tong B; Wei Z; Dai Y
Oncotarget; 2016 Apr; 7(17):23684-99. PubMed ID: 27008697
[TBL] [Abstract][Full Text] [Related]
18. LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1 signalling pathway.
Cuevas EP; Eraso P; Mazón MJ; Santos V; Moreno-Bueno G; Cano A; Portillo F
Sci Rep; 2017 Mar; 7():44988. PubMed ID: 28332555
[TBL] [Abstract][Full Text] [Related]
19. New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins.
Eraso P; Mazón MJ; Jiménez V; Pizarro-García P; Cuevas EP; Majuelos-Melguizo J; Morillo-Bernal J; Cano A; Portillo F
Molecules; 2023 May; 28(11):. PubMed ID: 37298909
[TBL] [Abstract][Full Text] [Related]
20. Tumor-secreted LOXL2 activates fibroblasts through FAK signaling.
Barker HE; Bird D; Lang G; Erler JT
Mol Cancer Res; 2013 Nov; 11(11):1425-36. PubMed ID: 24008674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
